MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN

Biochemical and Biophysical Research Communications

Volumn 440, Issue 4, 2013, Pages 604-610

  Li, Yan ^a   Li, Li ^b   Guan, Yan ^a   Liu, Xiuju ^a   Meng, Qingyong ^c   Guo, Qisen ^a  

^a UNIVERSITY OF JINAN   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c No 6 People's Hospital of Jinan   (China)

Author keywords

CDDP; Cell growth; MiR 92b; NSCLC; PTEN

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 92B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84887110965     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.111     Document Type: Article

References (36)

1. S. Subramaniam, R.K. Thakur, V.K. Yadav, R. Nanda, S. Chowdhury, and A. Agrawal Lung cancer biomarkers: state of the art J. Carcinog. 12 2013 3
2. A. Jemal, M.J. Thun, L.A. Ries, H.L. Howe, H.K. Weir, M.M. Center, E. Ward, X.C. Wu, C. Eheman, R. Anderson, U.A. Ajani, B. Kohler, and B.K. Edwards Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control J. Natl Cancer Inst. 100 2008 1672 1694
3. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat. Rev. Drug Discov. 5 2006 219 234
4. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
5. A. Esquela-Kerscher, and F.J. Slack Oncomirs-microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
6. Y. Akao, S. Noguchi, A. Iio, K. Kojima, T. Takagi, and T. Naoe Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells Cancer Lett. 300 2011 197 204
7. H. Shibuya, H. Iinuma, R. Shimada, A. Horiuchi, and T. Watanabe Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer Oncology 79 2010 313 320
8. C.C. Yu, Y.W. Chen, G.Y. Chiou, L.L. Tsai, P.I. Huang, C.Y. Chang, L.M. Tseng, S.H. Chiou, S.H. Yen, M.Y. Chou, P.Y. Chu, and W.L. Lo MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation Oral Oncol. 47 2011 202 210
9. E. Tili, J.J. Michaille, D. Wernicke, H. Alder, S. Costinean, S. Volinia, and C.M. Croce Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer Proc. Natl. Acad. Sci. U. S. A. 108 2011 4908 4913
10. U. Vosa, T. Vooder, R. Kolde, K. Fischer, K. Valk, N. Tonisson, R. Roosipuu, J. Vilo, A. Metspalu, and T. Annilo Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer Genes Chromosom. Cancer 50 2011 812 822
11. L. Yu, N.W. Todd, L. Xing, Y. Xie, H. Zhang, Z. Liu, H. Fang, J. Zhang, R.L. Katz, and F. Jiang Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers Int. J. Cancer 127 2010 2870 2878
12. P. Guan, Z. Yin, X. Li, W. Wu, and B. Zhou Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues J. Exp. Clin. Cancer Res. 31 2012 54
13. R. Wang, Z.X. Wang, J.S. Yang, X. Pan, W. De, and L.B. Chen MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 RAB14 Oncogene 30 2011 2644 2658
14. X. Fu, J. Tian, L. Zhang, Y. Chen, and Q. Hao Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells FEBS Lett. 586 2012 1279 1286
15. M. Tamura, J. Gu, H. Tran, and K.M. Yamada PTEN gene and integrin signaling in cancer J. Natl Cancer Inst. 91 1999 1820 1828
16. R. Hummel, D.J. Hussey, and J. Haier MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types Eur. J. Cancer 46 2010 298 311
17. K. Bhatt, L. Zhou, Q.S. Mi, S. Huang, J.X. She, and Z. Dong MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival Mol. Med. 16 2010 409 416
18. A.A. Shah, P. Leidinger, N. Blin, and E. Meese MiRNA: small molecules as potential novel biomarkers in cancer Curr. Med. Chem. 17 2010 4427 4432
19. F. Meng, S.S. Glaser, H. Francis, S. DeMorrow, Y. Han, J.D. Passarini, A. Stokes, J.P. Cleary, X. Liu, J. Venter, P. Kumar, S. Priester, L. Hubble, D. Staloch, J. Sharma, C.G. Liu, and G. Alpini Functional analysis of microRNAs in human hepatocellular cancer stem cells J. Cell Mol. Med. 16 2012 160 173
20. T.A. Farazi, J.I. Spitzer, P. Morozov, and T. Tuschl MiRNAs in human cancer J. Pathol. 223 2011 102 115
21. X.H. Liu, K.H. Lu, K.M. Wang, M. Sun, E.B. Zhang, J.S. Yang, D.D. Yin, Z.L. Liu, J. Zhou, Z.J. Liu, W. De, and Z.X. Wang MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5 BMC Cancer 12 2012 348
22. H.M. Cho, H.S. Jeon, S.Y. Lee, K.J. Jeong, S.Y. Park, H.Y. Lee, J.U. Lee, J.H. Kim, S.J. Kwon, E. Choi, M.J. Na, J. Kang, and J.W. Son MicroRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2 Exp. Ther. Med. 2 2011 963 967
23. J. Kang, S.Y. Lee, S.Y. Lee, Y.J. Kim, J.Y. Park, S.J. Kwon, M.J. Na, E.J. Lee, H.S. Jeon, and J.W. Son MicroRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3 Exp. Ther. Med. 3 2012 149 153
24. S. Xiong, Y. Zheng, P. Jiang, R. Liu, X. Liu, and Y. Chu MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2 Int. J. Biol. Sci. 7 2011 805 814
25. S. Feng, S. Cong, X. Zhang, X. Bao, W. Wang, H. Li, Z. Wang, G. Wang, J. Xu, B. Du, D. Qu, W. Xiong, M. Yin, X. Ren, F. Wang, J. He, and B. Zhang MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells Nucleic Acids Res. 39 2011 6669 6678
26. G. Dalmasso, H.T. Nguyen, Y. Yan, H. Laroui, M.A. Charania, T.S. Obertone, S.V. Sitaraman, and D. Merlin MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells Am. J. Physiol. Gastrointest. Liver Physiol. 300 2011 G52 59
27. B.H. Haug, J.R. Henriksen, J. Buechner, D. Geerts, E. Tomte, P. Kogner, T. Martinsson, T. Flaegstad, B. Sveinbjornsson, and C. Einvik MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma Carcinogenesis 32 2011 1005 1012
28. K. Wang, X. Wang, J. Zou, A. Zhang, Y. Wan, P. Pu, Z. Song, C. Qian, Y. Chen, S. Yang, and Y. Wang MiR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase Neuro Oncol. 15 2013 578 588
29. S. Sengupta, J. Nie, R.J. Wagner, C. Yang, R. Stewart, and J.A. Thomson MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells Stem cells 27 2009 1524 1528
30. J.C. Reed Mechanisms of apoptosis avoidance in cancer Curr. Opin. Oncol. 11 1999 68 75
31. I. Judson, and L.R. Kelland New developments and approaches in the platinum arena Drugs 59 Suppl. 4 2000 29 36 discussion 37-28
32. W. Gao, X. Lu, L. Liu, J. Xu, D. Feng, and Y. Shu MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer Cancer Biol. Ther. 13 2012 330 340
33. T. Qiu, L. Zhou, T. Wang, J. Xu, J. Wang, W. Chen, X. Zhou, Z. Huang, W. Zhu, Y. Shu, and P. Liu MiR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2 Int. J. Mol. Med. 32 2013 593 598
34. L. Galluzzi, E. Morselli, I. Vitale, O. Kepp, L. Senovilla, A. Criollo, N. Servant, C. Paccard, P. Hupe, T. Robert, H. Ripoche, V. Lazar, A. Harel-Bellan, P. Dessen, E. Barillot, and G. Kroemer MiR-181a and miR-630 regulate cisplatin-induced cancer cell death Cancer Res. 70 2010 1793 1803
35. M. Tanaka, and H.B. Grossman In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin Gene Ther. 10 2003 1636 1642
36. L.C. Cantley, and B.G. Neel New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proc. Natl. Acad. Sci. U. S. A. 96 1999 4240 4245